The Role of Surgery in Stage IV Ovarian Cancer

Insights from 2024 ESMO Gynaecological Cancers Congress

C. Fotopoulou

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Yale School of Medicine

M. Minkin, E. Ratner

Referral to Eye Care Provider for Management of Ocular Toxicity Asso…

Debra Richardson

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comparing…

Insights from 2023 ESGO Annual Meeting

A. Clamp

Updates in Ovarian Cancer: Risk Reduction Strategies and Mirvetuxima…

Nebraska Oncology Society

M. Clark

Expert Panel Case Discussion: Stage 4A High-Grade Serous Epithelial …

Integrity CE

M. Murphy, E. Teplinsky, M. Finkel

SGO 2023 Phase 3 UP-NEXT Trial: Upifitamab Rilsodotin, a NaPi2b-Dire…

SGO 2023 Conference Coverage on VuMedi

D. Richardson

Updates in Gynecologic Cancers: Ovarian Cancer

Yale Cancer Center

M. Clark

Detection of Residual Peritoneal Metastases Following Cytoreductive …

Penn Medicine Abramson Cancer Center

P. Wagner

2020 ASCO Update on PARPi in Ovarian Cancer: Is BRCA Related to Ther…

2020 ASCO Virtual Direct™ Highlights

S. Temkin

Expert Panel Case Discussion: 45 y/o With Recurrent Stage 3A Platinu…

Integrity CE

M. Murphy, E. Teplinsky, M. Finkel

2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Surviv…

Total Health

A. Smith